38801839|t|Oral administration of liposome-encapsulated thymol could alleviate the inflammatory parameters in serum and hippocampus in a rat model of Alzheimer's disease.
38801839|a|BACKGROUND: Neuroinflammation is closely related to Alzheimer's Disease (AD) pathology, hence supplements with anti-inflammatory property could help attenuate the progression of AD. This study was conducted to evaluate the potential anti-inflammatory effects of liposome encapsulated thymol (LET), administered orally, in prevention of Alzheimer in a rat model by anti-inflammatory mechanisms. METHODS: The rats were grouped into six groups (n = 10 animals per group), including Control healthy (Con), Alzheimer's disease (AD) model, AD model treated with free thymol in 40 and 80 mg/kg body weight (TH40 and TH80), AD model treated with LET in 40 and 80 mg/kg of body weight (LET40 and LET80). The behavioral response of step through latency (Passive Avoidance Test), concentrations of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) and cyclooxygenase-2 (COX-2) and brain-derived neurotrophic factor (BDNF) were assessed in serum and hippocampus. RESULTS: The results showed that significant increase in concentrations of IL-1beta (P = 0.001), IL-6 (P = 0.001), TNF-alpha (P = 0.001) and COX-2 (P = 0.001) in AD group compared with healthy control rats. AD induction significantly reduced step through latency and revealed deficits in passive avoidance performance. The results also showed the treatment with free thymol especially in higher concentrations and also LTE could decrease serum concentrations of IL-1beta (P < 0.05), IL-6 (P < 0.05), TNF-alpha (P < 0.05), and COX-2 (P < 0.05) and increase BDNF (P < 0.05) compared with control Alzheimer rats in hippocampus and serum. There were also significant correlations between serum and hippocampus concentrations of IL-1beta (r2 = 0.369, P = 0.001), IL-6 (r2 = 0.386, P = 0.001), TNF-alpha (r2 = 0.412, P = 0.001), and COX-2 (r2 = 0.357, P = 0.001). It means a closed and positive relation between serum and hippocampus concentrations of IL-1beta, IL-6, TNF-alpha, and COX-2. CONCLUSIONS: LET demonstrates its ability to attenuate neuroinflammatory reaction in AD model through suppression of IL-1beta, IL-6, and TNF-alpha and COX-2 indicators. Hence, it can ameliorate AD pathogenesis by declining inflammatory reaction.
38801839	45	51	thymol	Chemical	MESH:D013943
38801839	72	84	inflammatory	Disease	MESH:D007249
38801839	126	129	rat	Species	10116
38801839	139	158	Alzheimer's disease	Disease	MESH:D000544
38801839	172	189	Neuroinflammation	Disease	MESH:D000090862
38801839	212	231	Alzheimer's Disease	Disease	MESH:D000544
38801839	233	235	AD	Disease	MESH:D000544
38801839	276	288	inflammatory	Disease	MESH:D007249
38801839	338	340	AD	Disease	MESH:D000544
38801839	398	410	inflammatory	Disease	MESH:D007249
38801839	444	450	thymol	Chemical	MESH:D013943
38801839	452	455	LET	Chemical	-
38801839	496	505	Alzheimer	Disease	MESH:D000544
38801839	511	514	rat	Species	10116
38801839	529	541	inflammatory	Disease	MESH:D007249
38801839	567	571	rats	Species	10116
38801839	662	681	Alzheimer's disease	Disease	MESH:D000544
38801839	683	685	AD	Disease	MESH:D000544
38801839	694	696	AD	Disease	MESH:D000544
38801839	721	727	thymol	Chemical	MESH:D013943
38801839	760	764	TH40	Chemical	-
38801839	769	773	TH80	Chemical	-
38801839	776	778	AD	Disease	MESH:D000544
38801839	798	801	LET	Chemical	-
38801839	947	964	interleukin-1beta	Gene	24494
38801839	966	974	IL-1beta	Gene	24494
38801839	977	990	interleukin-6	Gene	24498
38801839	992	996	IL-6	Gene	24498
38801839	1003	1030	tumor necrosis factor-alpha	Gene	24835
38801839	1032	1041	TNF-alpha	Gene	24835
38801839	1047	1063	cyclooxygenase-2	Gene	29527
38801839	1065	1070	COX-2	Gene	29527
38801839	1076	1109	brain-derived neurotrophic factor	Gene	24225
38801839	1111	1115	BDNF	Gene	24225
38801839	1232	1240	IL-1beta	Gene	24494
38801839	1254	1258	IL-6	Gene	24498
38801839	1272	1281	TNF-alpha	Gene	24835
38801839	1298	1303	COX-2	Gene	29527
38801839	1319	1321	AD	Disease	MESH:D000544
38801839	1358	1362	rats	Species	10116
38801839	1364	1366	AD	Disease	MESH:D000544
38801839	1524	1530	thymol	Chemical	MESH:D013943
38801839	1576	1579	LTE	Chemical	MESH:D017999
38801839	1619	1627	IL-1beta	Gene	24494
38801839	1640	1644	IL-6	Gene	24498
38801839	1657	1666	TNF-alpha	Gene	24835
38801839	1683	1688	COX-2	Gene	29527
38801839	1713	1717	BDNF	Gene	24225
38801839	1751	1760	Alzheimer	Disease	MESH:D000544
38801839	1761	1765	rats	Species	10116
38801839	1881	1889	IL-1beta	Gene	24494
38801839	1915	1919	IL-6	Gene	24498
38801839	1945	1954	TNF-alpha	Gene	24835
38801839	1984	1989	COX-2	Gene	29527
38801839	2103	2111	IL-1beta	Gene	24494
38801839	2113	2117	IL-6	Gene	24498
38801839	2119	2128	TNF-alpha	Gene	24835
38801839	2134	2139	COX-2	Gene	29527
38801839	2154	2157	LET	Chemical	-
38801839	2196	2213	neuroinflammatory	Disease	MESH:D000090862
38801839	2226	2228	AD	Disease	MESH:D000544
38801839	2258	2266	IL-1beta	Gene	24494
38801839	2268	2272	IL-6	Gene	24498
38801839	2278	2287	TNF-alpha	Gene	24835
38801839	2292	2297	COX-2	Gene	29527
38801839	2335	2337	AD	Disease	MESH:D000544
38801839	2364	2376	inflammatory	Disease	MESH:D007249
38801839	Positive_Correlation	MESH:D000544	29527
38801839	Positive_Correlation	MESH:D000544	24494
38801839	Negative_Correlation	MESH:D017999	24494
38801839	Negative_Correlation	MESH:D013943	MESH:D007249
38801839	Positive_Correlation	MESH:D013943	24225
38801839	Negative_Correlation	MESH:D017999	24498
38801839	Positive_Correlation	MESH:D017999	24225
38801839	Negative_Correlation	MESH:D013943	24498
38801839	Positive_Correlation	MESH:D000544	24498
38801839	Negative_Correlation	MESH:D017999	29527
38801839	Negative_Correlation	MESH:D013943	24835
38801839	Negative_Correlation	MESH:D013943	MESH:D000544
38801839	Negative_Correlation	MESH:D017999	24835
38801839	Negative_Correlation	MESH:D013943	24494
38801839	Positive_Correlation	MESH:D000544	24835
38801839	Negative_Correlation	MESH:D013943	29527

